FDA Approves Expanded Monotherapy Label for Merck’s Keytruda (pembrolizumab) for First-Line Treatment of NSCLC

Print this page KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for Keytruda, Merck’s anti-PD-1 therapy, as monotherapy for the first-line treatment of patients with stage III non-small cell lung cancer (NSCLC) who are not… Read More: FDA Approves Expanded Monotherapy Label for Merck’s Keytruda (pembrolizumab) for… »

The dog ate my hearing aid! Surprising ways people lose their hearing aids

Americans spend an average total of 2.5 days every year looking for lost belongings such as remote controls, cellphones, car keys and eyeglasses, one survey indicates.  The biggest reason for hearing aid loss?The family dog uses them as a chew toy,says Audiologist Melissa Danchak. And while two-thirds of us annually spend as much as $ 50 to… Read More: The dog ate my hearing aid! Surprising ways people lose… »

Medical News Today: Study finds that many people diagnosed with MS do not have the condition

Researchers found that nearly 1 in 5 people who had received a diagnosis of multiple sclerosis had other unrelated conditions. Some conditions, such as stroke or migraine, have similar symptoms to MS. Multiple sclerosis (MS) is a widespread disabling neurological condition in which the immune system attacks and destroys the fatty tissue that surrounds the… Read More: Medical News Today: Study finds that many people diagnosed with… »